Prevention of Nosocomial Infections in Critically Ill Patients With Lactoferrin: The PREVAIL Study

PHASE2CompletedINTERVENTIONAL
Enrollment

214

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

September 12, 2016

Study Completion Date

September 12, 2016

Conditions
Critically Ill
Interventions
DIETARY_SUPPLEMENT

Lactoferrin

Lactoferrin is an 80 kilodalton (kD) naturally occurring multifunctional glycoprotein of the transferrin family which is an important component of the human innate immune system. Lactoferrin is distributed widely in humans with the main sources of production being exocrine glands and specific granules of neutrophils. It is present in virtually all human secretions. The highest concentrations are found in milk and colostrum. Lactoferrin has multiple biological functions which make it of interest as a therapeutic agent in the critically ill. These include the ability to bind iron, antimicrobial activity including antibacterial, antifungal, antiviral properties, the ability to bind endotoxin, promotion of beneficial bacteria in the gastro-intestinal tract and immunomodulatory activity.

OTHER

Placebo

Sterile water will be utilized as the placebo control in this double blind randomized-controlled trial.

Trial Locations (1)

K7L 2V7

Kingston General Hospital, Kingston

All Listed Sponsors
lead

Queen's University

OTHER

NCT01996579 - Prevention of Nosocomial Infections in Critically Ill Patients With Lactoferrin: The PREVAIL Study | Biotech Hunter | Biotech Hunter